CANY
NPTN

Caxton Associates (New York)’s NEOPHOTONICS CORP NPTN Stock Holding History

Caxton Associates (New York)’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50,503
Closed -$448K – 562
2020
Q2 		$448K Buy
+50,503
New +$435K 0.04% 160

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Caxton Associates (New York)'s NPTN Position: Q3 2020 in Review

Caxton Associates (New York) sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 50,503 shares — an estimated $448K sold.

Caxton Associates (New York) first reported a position in NPTN in Q2 2020 and held it in 1 quarter. The position peaked at $448K in Q2 2020. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

  • Caxton Associates (New York) reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 50,503 NEOPHOTONICS CORP shares in Q3 2020, an estimated $448K.
  • Caxton Associates (New York) first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 1 quarter.
  • Caxton Associates (New York)'s NEOPHOTONICS CORP position peaked at $448K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on Caxton Associates (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.